QQ客服 官方微博 反馈留言

	Enhancement of the efficacy of mesenchymal stem cells in the treatment of ischemic diseases.
	Luo Ruixi; Lu Yanrong; Liu Jingping; Cheng Jingqiu; Chen Younan
刊名	Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
	2019
卷号	Vol.109页码:2022-2034
关键词	Cell therapy Cell transplantation Ischemic disease Mesenchymal stem cell
ISSN号	1950-6007
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1822747
专题	四川大学
作者单位	Key Laboratory of Transplant Engineering and Immunology, NHFPC, Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, PR China. Key Laboratory of Transplant Engineering and Immunology, NHFPC, Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, PR China. Electronic address: jqcheng@scu.edu.cn. Key Laboratory of Transplant Engineering and Immunology, NHFPC, Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, PR China. Electronic address: chenyounan@scu.edu.cn.
推荐引用方式 GB/T 7714	Luo Ruixi,Lu Yanrong,Liu Jingping,et al. Enhancement of the efficacy of mesenchymal stem cells in the treatment of ischemic diseases.[J]. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,2019,Vol.109:2022-2034.
APA	Luo Ruixi,Lu Yanrong,Liu Jingping,Cheng Jingqiu,&Chen Younan.(2019).Enhancement of the efficacy of mesenchymal stem cells in the treatment of ischemic diseases..Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,Vol.109,2022-2034.
MLA	Luo Ruixi,et al."Enhancement of the efficacy of mesenchymal stem cells in the treatment of ischemic diseases.".Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Vol.109(2019):2022-2034.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。